Akcea Therapeutics Inc
AKCA
AKCA was delisted on the 9th of October, 2020.
98 hedge funds and large institutions have $287M invested in Akcea Therapeutics Inc in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 19 closing their positions.
74% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 19
21% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 24
17% more funds holding
Funds holding: 84 → 98 (+14)
7% more capital invested
Capital invested by funds: $268M → $287M (+$19M)
78% less call options, than puts
Call options by funds: $553K | Put options by funds: $2.47M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GF
Gabelli Funds
Rye,
New York
|
+$8.51M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$5.48M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$5.35M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.47M |
| 5 |
WIC
Water Island Capital
New York
|
+$3.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$69.4M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$15.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.53M |
| 4 |
D.E. Shaw & Co
New York
|
-$3.19M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.79M |
AKCA Hedge Fund Activity: Q3 2020 in Review
98 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q3 2020, worth a combined $287M — up 7.1% from $268M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new AKCA positions and 19 closed out — a net gain of 14 holders — while 29 added to existing stakes and 24 trimmed.
The largest buyer was Gabelli Funds, opening a new position worth an estimated $8.51M. The largest seller was Fidelity Investments, cutting an estimated $69.4M.
- 98 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q3 2020, up from 84 in Q2 2020.
- Funds reported $287M of Akcea Therapeutics Inc stock for Q3 2020, up 7.1% quarter-over-quarter.
- 33 funds opened new Akcea Therapeutics Inc positions in Q3 2020 and 19 closed out, a net change of +14 holders.
- The largest Akcea Therapeutics Inc buyer in Q3 2020 was Gabelli Funds, an estimated $8.51M added.
- The largest Akcea Therapeutics Inc seller in Q3 2020 was Fidelity Investments, an estimated $69.4M sold.
Based on aggregated 13F filings for Q3 2020.